Division of Gastroenterology, Department of Internal Medicine, Inha University School of Medicine, Incheon, South Korea.
Yonsei University College of Medicine, Seoul, South Korea.
Endoscopy. 2019 Feb;51(2):125-132. doi: 10.1055/a-0639-5147. Epub 2018 Jul 3.
Endoscopic papillary large balloon dilation (EPLBD) without prior endoscopic sphincterotomy (EST) produces excellent outcomes for the treatment of large common bile duct (CBD) stones. However, it remains unclear how the outcomes of EPLBD alone compare with those of EPLBD with EST. In this study, we assessed the safety and therapeutic outcomes of EPLBD with vs. without EST for the removal of large bile duct stones.
This prospective, multicenter study was conducted on 200 patients with bile duct stones of ≥ 10 mm in diameter. Patients were randomly assigned to an EPLBD alone group (n = 100) or an EPLBD with EST group (n = 100). These two groups were compared with respect to overall procedure-related adverse events, overall stone removal success rate, number of endoscopic sessions required for complete stone removal, need for mechanical lithotripsy, and total procedure time.
The incidence of adverse events was not significantly different between the groups (EPLBD alone vs. EPLBD with EST: overall adverse events 6 % vs. 4 %, = 0.75; pancreatitis 1 % vs. 3 %, = 0.62). Overall success ( = 0.35), initial success ( = 0.28), and the need for mechanical lithotripsy ( = 0.39) were also similar between groups. Median total procedure time tended to be greater in the EPLBD alone group (20.5 minutes) than in the EPLBD with EST group (18 minutes; = 0.08).
The therapeutic outcomes and adverse events of EPLBD alone for the removal of large bile duct stones were comparable to those of EPLBD with EST.
内镜下乳头大球囊扩张(EPLBD)无需先行内镜下括约肌切开术(EST)即可治疗胆总管(CBD)大结石,效果良好。但 EPLBD 单独应用与联合 EST 应用治疗大胆管结石的效果对比情况尚不清楚。本研究旨在评估单独应用 EPLBD 与联合 EST 应用 EPLBD 治疗大胆管结石的安全性和疗效。
前瞻性、多中心研究纳入了 200 例胆管结石直径≥10mm 的患者。患者被随机分配至单独 EPLBD 组(n=100)或 EPLBD 联合 EST 组(n=100)。比较两组患者的整体手术相关不良事件发生率、整体取石成功率、完全取石所需的内镜操作次数、机械碎石的需求以及总手术时间。
两组患者不良事件的发生率无显著差异(单独 EPLBD 组与 EPLBD 联合 EST 组:整体不良事件 6% vs. 4%, = 0.75;胰腺炎 1% vs. 3%, = 0.62)。整体成功率( = 0.35)、初始成功率( = 0.28)和机械碎石的需求( = 0.39)也相似。单独 EPLBD 组的中位总手术时间(20.5 分钟)长于 EPLBD 联合 EST 组(18 分钟; = 0.08)。
单独应用 EPLBD 治疗大胆管结石的疗效和不良事件与联合 EST 应用 EPLBD 治疗大胆管结石的疗效和不良事件相当。